mirvetuximab soravtansine

Italy

Drugs containing this active substance

  • ELAHERE

    It is an anticancer drug used for the treatment of adults with ovarian cancer, Fallopian tube cancer, or primary peritoneal cancer, in patients whose cancer cells express the folate receptor alpha (FRα) protein and who have not responded or no longer respond to platinum-based chemotherapy after receiving one to three previous treatments.

    Form: solution for infusion, concentrate

    Active substance Dosage
    mirvetuximab soravtansine -

    ATC: L01FX26

    Manufacturer: ABBVIE DEUTSCHLAND GMBH & CO. KG